La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « ISSN » - entrée « 0091-3952 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0091-3057 < 0091-3952 < 0091-4916  Facettes :

List of bibliographic references indexed by 0091-3952

Number of relevant bibliographic references: 94.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
002963 (2005) Valerie Voon [Canada] ; Elena Moro ; Jean A. Saint-Cyr ; Andres M. Lozano ; Anthony E. LangPsychiatric symptoms following surgery for Parkinson's disease with an emphasis on subthalamic stimulation.
002991 (2005) Sharon Cohen [Canada] ; Morris FreedmanCognitive and behavioral changes in the Parkinson-plus syndromes.
002994 (2005) Jean A. Saint-Cyr [Canada]Basal ganglia: functional perspectives and behavioral domains.
002B52 (2004) Yoshiaki Furukawa [Canada]Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.
002D54 (2003) Joseph King Ching Tsui [Canada]Treatment of dystonia in Parkinson's disease.
002D67 (2003) Donald B. Calne [Canada]Parkinson's disease over the last 100 years.
002D86 (2003) A Jon Stoessl [Canada] ; Raúl De La Fuente-FernándezDopamine receptors in Parkinson's disease: imaging studies.
002E92 (2003) Susan M. Calne [Canada] ; Edwin Mak [Canada] ; Jeanne Hall [Canada] ; Marie-Jose Fortin [Canada] ; Pamela King [Canada] ; Germaine Mcinnes [Canada] ; Linda Grantier [Canada] ; Sherree Trecartin [Canada] ; Michael Schulzer [Canada]Validating a quality-of-life scale in caregivers of patients with Parkinson's disease: Parkinson's impact scale (PIMS)
002E95 (2003) Joseph King Ching Tsui [Canada]Treatment of dystonia in Parkinson's disease
002F00 (2003) Andres M. Lozano [Canada]Surgery for Parkinson's disease, the five W's: Why, who, what, where, and when
002F05 (2003) Pierre J. Blanchet [États-Unis, Canada] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis]Renaissance of amantadine in the treatment of Parkinson's disease
002F18 (2003) A. Hadj Tahar [Canada] ; R. Grondin [Canada] ; L. Gregoire [Canada] ; F. Calon [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada]New insights in Parkinson's disease therapy: Can levodopa-induced dyskinesia ever be manageable
002F22 (2003) Ajit Kumar [Canada] ; ZHIGAO HUANG [Canada] ; Raul De La Fuente-Fernandez [Canada]Mechanisms of motor complications in treatment of Parkinson's disease
002F33 (2003) Yoshiaki Furukawa [Canada]Genetics and biochemistry of dopa-responsive dystonia: Significance of striatal tyrosine hydroxylase protein loss
002F37 (2003) Alex Rajput [Canada] ; Michele Rajput [Canada]Essential tremor and Parkinsonism
002F40 (2003) A. Jon Stoessl [Canada] ; Raul De La Fuente-Fernandez [Canada]Dopamine receptors in Parkinson's disease: Imaging studies
002F50 (2003) Stephen J. Kish [Canada]Biochemistry of Parkinson's disease: Is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
003068 (2002) Mohamed Shafiq [Canada] ; Anthony E. Lang [Canada]Myoclonus in parkinsonian disorders
003273 (2001) Parkinson's disease
003274 (2001) J. Thomas Hutton [États-Unis] ; Jerry L. Morris [États-Unis]Vision in Parkinson's disease
003277 (2001) Ali H. Rajput [Canada]The protective role of levodopa in the human substantia nigra
003278 (2001) Kurt A. Jellinger [Autriche]The pathology of Parkinson's disease
003279 (2001) Serge Przedborski [États-Unis] ; Miquel VilaThe last decade in Parkinson's disease research: Basic sciences
003280 (2001) Stephen A. Marion [Canada]The epidemiology of Parkinson's disease: Current issues
003281 (2001) Andrzej Friedman [Pologne] ; Jolanta Galazka-Friedman [Pologne]The current state of free radicals in Parkinson's disease: Nigral iron as a trigger of oxidative stress
003282 (2001) Lauri V. Laitinen [Suède]Surgical treatment for Parkinson's disease over the last decade
003283 (2001) C. Warren Olanow [États-Unis] ; Mitchell F. Brin [États-Unis]Surgical therapies for Parkinson's disease: A physician's perspective
003285 (2001) Thomas N. Chase [États-Unis] ; Spiridon Konitsiotis [États-Unis] ; Justin D. Oh [États-Unis]Striatal molecular mechanisms and motor dysfunction in Parkinson's disease
003286 (2001) Fabrizio Stocchi [Italie] ; Laura Vacca [Italie] ; Marcella Valente [Italie] ; Stefano Ruggieri [Italie]Sleep disorders in Parkinson's disease
003287 (2001) Rosemary Basson [Canada]Sex and idiopathic Parkinson's disease
003288 (2001) Vijay Dhawan [États-Unis] ; David Eidelberg [États-Unis]SPECT imaging in Parkinson's disease
003289 (2001) Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Daniel Levesque [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model
003290 (2001) Erik Ch. Wolters [Pays-Bas]Psychiatric complications in the treatment of Parkinson's disease
003291 (2001) Andreas Hartmann [France] ; Etienne C. Hirsch [France]Parkinson's disease: The apoptosis hypothesis revisited
003292 (2001) Andres M. Lozano [Canada] ; Anthony E. Lang [Canada]Pallidotomy for Parkinson's disease
003294 (2001) Doris J. Doudet [Canada]PET studies in the MPTP model of Parkinson's disease
003295 (2001) Amos D. Korczyn [Israël]Neuropsychiatric manifestations in Parkinson's disease
003296 (2001) A. Jon Stoessl [Canada]Neurochemical and neuroreceptor imaging with PET in Parkinson's disease
003297 (2001) Thomas B. Freeman [États-Unis] ; Allison Willing [États-Unis] ; Tanya Zigova [États-Unis] ; Paul R. Sanberg [États-Unis] ; Robert A. Hauser [États-Unis]Neural transplantation in Parkinson's disease
003298 (2001) Peter Riederer [Allemagne] ; Heinz Reichmann [Allemagne] ; Bernd Janetzky [Allemagne] ; Jeswinder Sian [Allemagne] ; Klaus-Peter Lesch [Allemagne] ; Klaus W. Lange [Allemagne] ; K. L. Double [Allemagne] ; Toshiharu Nagatsu [Japon] ; Manfred Gerlach [Allemagne]Neural degeneration in Parkinson's disease
003300 (2001) Thomas Gasser [Allemagne]Molecular genetics of Parkinson's disease
003303 (2001) W. R. Wayne Martin [Canada]Magnetic resonance imaging and spectroscopy in Parkinson's disease
003309 (2001) Patrick L. Mcgeer [Canada] ; Koji Yasojima [Canada] ; Edith G. Mcgeer [Canada]Inflammation in Parkinson's disease
003311 (2001) Hitoshi Shinotoh [Japon] ; Hiroki Namba [Japon] ; Mika Yamaguchi [Japon] ; Kiyoshi Fukushi [Japon] ; Shin-Ichiro Nagatsuka [Japon] ; Masaomi Iyo [Japon] ; Masato Asahina [Japon] ; Takamichi Hattori [Japon] ; Shuji Tanada [Japon] ; Toshiaki Irie [Japon]In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy
003313 (2001) Ole Isacson [États-Unis] ; Craig Van Horne [États-Unis] ; James M. Schumacher [États-Unis] ; Anna-Liisa Brownell [États-Unis]Improved surgical cell therapy in Parkinson's disease: Physiological basis and new transplantation methodology
003315 (2001) Kirk A. Frey [États-Unis] ; Robert A. Koeppe ; Michael R. KilbournImaging the vesicular monoamine transporter
003317 (2001) Kevin St. P. Mcnaught [Royaume-Uni] ; Moonhee Lee [Royaume-Uni] ; Dong-Hoon Hyun [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Glial cells and abnormal protein handling in the pathogenesis of Parkinson's disease
003319 (2001) Nir Giladi [Israël]Gait disturbances in advanced stages of Parkinson's disease
003320 (2001) David B. Ramsden [Royaume-Uni] ; Richard B. Parsons [Royaume-Uni] ; Shu-Leong Ho [Hong Kong] ; TAO XIE [États-Unis] ; Rosemary Hope Waring [Royaume-Uni] ; Adrian Charles Williams [Hong Kong]Further studies in xenobiotic metabolism and Parkinson's disease
003322 (2001) John G. Nutt [États-Unis]Fluctuations in response to treatment for Parkinson's disease
003323 (2001) Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon] ; Tohru Kitada [Japon] ; Hiroto Matsumine [Japon] ; Hideo Mori [Japon] ; Hideki Shimura [Japon] ; Shinichiro Kubo [Japon] ; Hirokazu Kobayashi [Japon] ; Shuichi Asakawa [Japon] ; Shinsei Minoshima [Japon] ; Nobuyoshi Shimizu [Japon]Familial Parkinson's disease: α-Synuclein and parkin

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "0091-3952" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "0091-3952" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0091-3952
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022